Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Simon Chiu |
Documentos disponibles escritos por este autor (1)
Refinar búsqueda
The role of nutrient-based epigenetic changes in buffering against stress, aging, and alzheimer’s disease / Simon Chiu en Psychiatric Clinics of North America, Año 2014 - Vol.37 No. 4 (Diciembre)
[artículo]
Título : The role of nutrient-based epigenetic changes in buffering against stress, aging, and alzheimer’s disease Tipo de documento: texto impreso Autores: Simon Chiu, Autor ; Michel A. Woodbury-Fariña, Autor ; Mujeeb U. Shad, Autor Fecha de publicación: 2020 Artículo en la página: pp. 591-623 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Demencia de Alzheimer, Cognición, Estrés, Dieta epigenética, Nutracéuticos Resumen: Converging evidence identifies stress-related disorders as putative risk factors for Alzheimer Disease (AD). This article reviews evidence on the complex interplay of stress, aging, and genes-epigenetics interactions. The recent classification of AD into preclinical, mild cognitive impairment, and AD offers a window for intervention to prevent, delay, or modify the course of AD. Link: ./index.php?lvl=notice_display&id=24242
in Psychiatric Clinics of North America > Año 2014 - Vol.37 No. 4 (Diciembre) . - pp. 591-623[artículo] The role of nutrient-based epigenetic changes in buffering against stress, aging, and alzheimer’s disease [texto impreso] / Simon Chiu, Autor ; Michel A. Woodbury-Fariña, Autor ; Mujeeb U. Shad, Autor . - 2020 . - pp. 591-623.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Psychiatric Clinics of North America > Año 2014 - Vol.37 No. 4 (Diciembre) . - pp. 591-623
Palabras clave: Demencia de Alzheimer, Cognición, Estrés, Dieta epigenética, Nutracéuticos Resumen: Converging evidence identifies stress-related disorders as putative risk factors for Alzheimer Disease (AD). This article reviews evidence on the complex interplay of stress, aging, and genes-epigenetics interactions. The recent classification of AD into preclinical, mild cognitive impairment, and AD offers a window for intervention to prevent, delay, or modify the course of AD. Link: ./index.php?lvl=notice_display&id=24242